However, in reality, this is not always the case. In Part 7 – the final instalment of our inaugural Life Sciences Industry Report – we look more closely at reporting from 2024 on the ...

The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI). Lengthy drug development timelines and complex regulatory ...

The fourth quarter of 2024 represented a remarkable period for the life sciences industry, driven by substantial funding rounds, regional growth, and notable advancements in healthcare. Through its ...

North Carolina employs 75,000 in the life sciences and our robust training programs continue to grow that pipeline. North Carolina’s life sciences industry offers a variety of jobs with various ...

Mar. 10, 2025 — Feral cats have long been suspects in killing native species reintroduced into Australian conservation areas. DNA testing of the carcasses puts ... The Yucca and the Moth: How ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor ...

From groundbreaking research to commercial breakthroughs, the awards celebrate the best of the best—those who are not just shaping Scotland’s life sciences industry today but defining its future.

New Jersey’s life sciences community is celebrating another ... s 32nd annual dinner meeting and innovation celebration, the industry association recognized those driving discovery.

Artificial Intelligence (AI) is revolutionising the life sciences industry, driving advancements in drug discovery, clinical trials, and precision medicine. The AI market in pharmaceuticals is ...

During SCOPE 2025, Pam Tenaerts, chief science officer (at the time of the interview) at Medable, took time out of her schedule to discuss the importance of representation in clinical trials to ensure ...